The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, October 13, 2021
Tezepelumab is being developed by AstraZeneca in collaboration with Amgen and is under Priority Review for patients with asthma in the US. The FDA ...
read more
Wednesday, October 13, 2021
ChemoCentryx announced that the FDA has approved TAVNEOS (avacopan), an orally administered selective complement 5a receptor inhibitor, as an ...
read more
Wednesday, October 13, 2021
Agenus Inc, an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to ...
read more
Takeda announced that a safety signal has emerged in Phase 2 studies of TAK-994, an investigational oral orexin agonist. As an immediate precautionary...
read more
Thursday, October 07, 2021
Bristol Myers Squibb announced that the European Medicines Agency (EMA) has validated its Marketing Authorization Application (MAA) for mavacamten, an...
read more
Thursday, October 07, 2021
Merck announced that molnupiravir (MK-4482, EIDD-2801), an investigational oral antiviral medicine, significantly reduced the risk of hospitalization ...
read more
Thursday, October 07, 2021
The submission includes recent results from the Phase 3 ENSEMBLE 2 study that found a booster of the Johnson & Johnson COVID-19 vaccine given 56 days ...
read more
Thursday, October 07, 2021
GE Healthcare announced that it has received approval from the U.S. Food and Drug Administration (FDA) to remove hypersensitivity to ‘blood and blood ...
read more
Thursday, October 07, 2021
The Food and Drug Administration (FDA) has granted Enhertu (trastuzumab deruxtecan), Breakthrough Therapy Designation (BTD) in the US for the ...
read more
Thursday, October 07, 2021
The FDA has approved brexucabtagene autoleucel (Tecartus, Kite Pharma, Inc.) for adult patients with relapsed or refractory B-cell precursor acute ...
read more
Thursday, October 07, 2021
Acer Therapeutics and its collaboration partner, RELIEF THERAPEUTICS, announced that the FDA has accepted for filing the New Drug Application (NDA) ...
read more
Thursday, October 07, 2021
EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, and ...
read more
Thursday, October 07, 2021
Specialist development pharmaceutical company AMZELL B.V. and the FDA have reached an agreement on the protocol for the Phase 3 trial of its infantile...
read more
Thursday, October 07, 2021
Amgen (NASDAQ: AMGN) and Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company pioneering precision medicines for brain ...
read more
Thursday, October 07, 2021
Bristol Myers Squibb announced the Phase 2 LATTICE-UC study evaluating deucravacitinib, a first-in-class, oral, selective tyrosine kinase 2 (TYK2) ...
read more